
Neurosurgery Resident @ColumbiaNeuro @nyphospital
Joined August 2020
- Tweets64
- Following99
- Followers154
- Likes72
Adrian Jimenez retweeted
Check out our new survey by @jimenezae17 + assessing QOL outcomes in #Chordoma patients!
We find that younger survivors, female survivors, and survivors currently undergoing treatment for chordoma are at high risk for adverse #QOL outcomes
Great work!
Adrian Jimenez retweeted
Here in @NeurosurgeryCNS,
@jimenezae17 + @tdazad performed a study with the Medicare Physician/ Supplier Procedure Summary
They reveal an increase in endoscopic transphenoidal surgery claims and a decrease in microscopic transphenoidal surgery claims from 2010-2020
Adrian Jimenez retweeted
Here in #ClinicalNeurologyandNeurosurgery, @KhalafallahAM+ introduces a new #socioeconomic educational intervention for improving socioeconomic knowledge among #neurosurgery trainees.
Read more here! tinyurl.com/md557ssz
@Sach_Chak @jlporrasMD @KuoCathleen @jimenezae17
Adrian Jimenez retweeted
Here,@jimenezae17 used #Bayesian methods to characterize post-op #outcomes in #frailty patients
mFI-5 scores may be useful in predicting short term #outcomes but not long term outcomes such as 90-day mortality
tinyurl.com/mpd84yew
@WorldNeurosurg @ColumbiaNeuro @HopkinsNsurg
Adrian Jimenez retweeted
Very excited for this special #Meningioma issue in #Neurosurgery Clinics
Thank you @DoctorZada & @rljensenmdphd for the opportunity to contribute
+ thank you to all additional contributing authors for making this a great issue! #Braintumor #Braincancer #BTAM #BTSM
Excited for the latest issue of #Neurosurgery Clinics focusing on #Meningioma, co-edited by @rljensenmdphd & myself
🙏🏼 Drs. @RussellLonser, Dan Resnick & contributing authors.
sciencedirect.com/journal/ne…
@USCBTC @NeurosurgeryUSC @KeckMedUSC @KECKSchool_USC @Meningioma_host
Adrian Jimenez retweeted
Join us in congratulating Dr. Amir Manbachi @AManbachi & Dr. Debraj Mukherjee @NeuroOncSurgery recipients of 2023 Johns Hopkins Catalyst Awards! They are among 37 other early career faculty members to receive this honor from @JohnsHopkins. 👏👏Amir & Raj tinyurl.com/2xreaea3
Adrian Jimenez retweeted
Congrats @jimenezae17+ for publishing results from the @ChordomaFDN survivorship survey
Younger co-survivors may be at higher risk for adverse emotional #QOL outcomes while 1/3rd of co-survivors do not know about available resources @WorldNeurosurg
Link: tinyurl.com/2mv8bk95
Adrian Jimenez retweeted
Here in @TheJNS,
@jimenezae17 and @Rrkotecha provide insight on key issues of clinical trial implementation in #NSGY
Futures workflows should include pre-pipeline discussions, joint feasibility meetings and final approval by an IRB
Great work!
Link: tinyurl.com/3ysfmf69
Adrian Jimenez retweeted
Congratulations to our 2023 Columbia Neurosurgery matches! Michael G. Argenziano, MS, MD, Adrian Jimenez MD, and Amitra K. Singh, MD!
Adrian Jimenez retweeted
Here,@JulianGendreau + @HameedFarrukh @jimenezae17 @YusufMehkri find fractionated RT offers unclear benefit at improving progression-free survival in clival Chordoma patients that achieve gross total resection
Further investigation is needed! @NeurosurgeryCNS @ChordomaFDN
Adrian Jimenez retweeted
Here, stellar med students @jimenezae17 + @pav_shah and residents @jlporrasMD + @tdazad developed ML models for predicting prolonged LOS, nonroutine discharges and high hospital charges for #skullbase meningioma patients
#JNLSB @NASBSorg
Check it out! tinyurl.com/2p94amud
Adrian Jimenez retweeted
Our latest in @NeurosurgeryCNS , work led by all star @HopkinsMedicine student @AndrewHersh96 and post bacc @tara_dedrickson, great @HopkinsNsurg @StanfordNsurg collab. @jimenezae17 @JoshuaDMateri @AnandMed @councilsns
Insightful comments via @DrDiGiorgio @NeurosurgUCSF
Adrian Jimenez retweeted
#OnlineFirst: A comparative analysis of the Hospital Frailty Risk Score in predicting postoperative outcomes among intracranial tumor patients thejns.org/view/journals/j-n…
Adrian Jimenez retweeted
Here in @TheJNS,
@jimenezae17,@migueangjim+colleagues show the Hospital Frailty Risk Score may be a more effective predictor of adverse outcomes when compared to ASA, CCI, mFI-11 and mFI-5.
Measured outcomes were post-op complications, extended LOS, 90-day readmission and more!
Adrian Jimenez retweeted
Utilizing the SEER database, @JulianGendreau, @jimenezae17, @KuoCathleen + collaborators from multiple institutions find unclear outcomes of using RT after achieving GTR for skull base chordoma patients. @WorldNeurosurg
More studies are needed!
Link: tinyurl.com/2p9bfau6
Adrian Jimenez retweeted
#JNLSB_Online
Machine Learning Models for Predicting Postoperative Outcomes following Skull Base Meningioma Surgery
#nsgy #skullbase #meningioma #machinelearning @HopkinsNsurg
thieme-connect.com/products/…
Adrian Jimenez retweeted
Excited to present our work @CNS_Update #CNS2022!
1st authors from our team included @RakovecMaureen @jimenezae17 @JulianGendreau
Grateful to @arasthagiri @lola_chambless @GarniBDarian for organizing, and looking forward to reconnecting with friends from around the world!
We're ready for #2022CNS @CNS_Update, are you? Meet our team who will be representing Johns Hopkins at #2022CNS.
Adrian Jimenez retweeted
284 million+ people worldwide suffer substance use disorders (SUDs), increasingly affecting #nsgy patients
@jimenezae17 @jlporrasMD @tdazad+ found SUDs significantly impacted readmission after #braintumor surgery #btsm
Check out results @WorldNeurosurg!
tinyurl.com/mr6fpc8m
Adrian Jimenez retweeted
Focused efforts on H3K27M-Altered DMGs among adults are lacking. Check out our collaboration with @NeuroOncSurgery @HopkinsNsurg, where we shed light and provided some answers. Grateful for the support and mentorship I gained throughout this project. sciencedirect.com/science/ar…
Adrian Jimenez retweeted
It's department award day! Congratulations to our amazing medical students who were recipients of the Harvey Cushing Medical Student Research Award today! Thanks so much for all you do!! @NeuroOncSurgery @HopkinsSpine @HopkinsMedicine






















































